You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 135 No. 10, October 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (52)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Melanoma
 •Alert me on articles by topic

Interval Nodes

The Forgotten Sentinel Nodes in Patients With Melanoma

Roger F. Uren, MD, FRACP; Robert Howman-Giles, MD, FRACP; John F. Thompson, MD, FRACS; William H. McCarthy, FRACS; Michael J. Quinn, FRACS; John M. Roberts, FRACP; Helen M. Shaw, PhD

Arch Surg. 2000;135:1168-1172.

Background  Any sentinel lymph node that receives lymph drainage directly from a primary melanoma site, regardless of its location, may contain metastatic disease. This is true even if the sentinel node does not lie in a recognized node field. Interval (in-transit) nodes that lie along the course of a lymphatic vessel between a primary melanoma site and a recognized node field are sometimes seen during lymphatic mapping for sentinel node biopsy. If drainage to such interval nodes is ignored by the surgeon during sentinel node biopsy, metastatic melanoma will be missed in some patients.

Hypothesis  When lymph drains directly from a cutaneous melanoma site to an interval node, that sentinel node has the same chance of harboring micrometastatic disease as a sentinel node in a recognized node field.

Design  Preoperative lymphoscintigraphy with technetiumTc 99m antimony trisulfide colloid was performed to define lymphatic drainage patterns and, since 1992, to locate the sentinel lymph nodes for surgical biopsy or for permanent skin marking of their location with point tattoos.

Setting  Melanoma unit of a university teaching hospital.

Patients  A total of 2045 patients with cutaneous melanoma were studied in 13 years.

Results  Interval nodes were found in 148 patients (7.2%). The incidence of interval nodes varied with the site of the primary melanoma. Interval nodes were more common with melanomas on the trunk than with those on the lower limbs. Micrometastatic disease was found in 14% of interval nodes that underwent biopsy as sentinel nodes. This incidence is similar to that found in sentinel nodes located in recognized node fields, confirming the potential clinical importance of interval nodes.

Conclusions  Interval nodes should be removed surgically along with any additional sentinel nodes in standard node fields if the sentinel node biopsy procedure is to be complete. In some patients, an interval node will be the only lymph node that contains metastatic disease.


From Nuclear Medicine and Diagnostic Ultrasound, RPAH Medical Centre, Newtown (Drs Uren, Howman-Giles, and Roberts); Sydney Melanoma Unit, Royal Prince Alfred Hospital, Sydney (Drs Thompson, McCarthy, Quinn, and Shaw); and the Departments of Medicine (Drs Uren, Howman-Giles, and Roberts) and Surgery (Drs Thompson, McCarthy, and Quinn), The University of Sydney, Sydney, New South Wales, Australia.


RELATED ARTICLE

Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2000;135(10):1234.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Randomized Study Comparing the Effectiveness of Methylene Blue Dye with Lymphazurin Blue Dye in Sentinel Lymph Node Biopsy for the Treatment of Cutaneous Melanoma
Liu et al.
Ann. Surg. Oncol. 2008;15:2412-2417.
ABSTRACT | FULL TEXT  

Effect of Multiple-Nodal Basin Drainage on Cutaneous Melanoma
Federico et al.
Arch Surg 2008;143:632-638.
ABSTRACT | FULL TEXT  

The Role of Interval Nodes in Sentinel Lymph Node Mapping and Dissection for Melanoma Patients
Matter et al.
JNM 2007;48:1607-1613.
ABSTRACT | FULL TEXT  

The Reproducibility in Routine Clinical Practice of Sentinel Lymph Node Identification by Pre-operative Lymphoscintigraphy in Patients with Cutaneous Melanoma
Uren et al.
Ann. Surg. Oncol. 2007;14:899-905.
ABSTRACT | FULL TEXT  

Significance of Multiple Lymphatic Basin Drainage in Truncal Melanoma Patients Undergoing Sentinel Lymph Node Biopsy
McHugh et al.
Ann. Surg. Oncol. 2006;13:1216-1223.
ABSTRACT | FULL TEXT  

Sentinel Lymph Node Biopsy in Melanoma
Uren
JNM 2006;47:191-195.
FULL TEXT  

A Sentinel Node Biopsy Does Not Increase the Incidence of In-Transit Metastasis in Patients With Primary Cutaneous Melanoma
van Poll et al.
Ann. Surg. Oncol. 2005;12:597-608.
ABSTRACT | FULL TEXT  

Lymphatic Mapping in the Molecular Era
Pawlik et al.
Ann. Surg. Oncol. 2004;11:362-374.
FULL TEXT  

Lymphatic Drainage of the Skin
Uren
Ann. Surg. Oncol. 2004;11:179S-185S.
ABSTRACT | FULL TEXT  

Staging Workup, Sentinel Node Biopsy, and Follow-up Tests for Melanoma: Update of Current Concepts
Johnson et al.
Arch Dermatol 2004;140:107-113.
ABSTRACT | FULL TEXT  

Lymphoscintigraphy for Sentinel Node Mapping Using a Hybrid SPECT/CT System
Even-Sapir et al.
JNM 2003;44:1413-1420.
ABSTRACT | FULL TEXT  

Patterns of Lymphatic Drainage from the Skin in Patients with Melanoma
Uren et al.
JNM 2003;44:570-582.
ABSTRACT | FULL TEXT  

Interval Sentinel Lymph Nodes in Melanoma
McMasters et al.
Arch Surg 2002;137:543-549.
ABSTRACT | FULL TEXT  

Micrometastasis to In-Transit Lymph Nodes From Extremity and Truncal Malignant Melanoma
Thelmo et al.
Ann. Surg. Oncol. 2001;8:444-448.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.